{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:40:53Z","timestamp":1711636853176},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":7906,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1987,9]]},"abstract":"<jats:p>6 patients with refractory anaemia with excess blasts (RAEB) were treated with a new oral anthracycline, idarubicin. 3 patients achieved complete remission, and the remaining 3 achieved partial remission. These responses were maintained for 8\u201360 wk, the longer durations being in the patients who achieved complete remission. Treatment was given on an outpatient basis, and all but 1 patient remained at home for most of the disease course. Unwanted effects were mild. It would thus appear that oral idarubicin is an effective treatment for RAEB, in addition to allowing outpatient management. Larger studies are required for futher evaluation.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1987.tb00770.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T03:47:55Z","timestamp":1279424875000},"page":"278-281","source":"Crossref","is-referenced-by-count":8,"title":["Successful oral chemotherapy with idarubicin in refractory anaemia with excess blasts"],"prefix":"10.1111","volume":"39","author":[{"given":"E.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Parapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1983.tb02852.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90451-0"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"The French\u2010American\u2010British (FAB) Co\u2010operative group. Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennet JM","year":"1982","journal-title":"Br J Haematol"},{"issue":"45","key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0609.1986.tb00853.x","article-title":"Natural course of myelodysplastic syndromes \u2010 Helsinki experience","volume":"36","author":"Teerenhovi L.","year":"1986","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_6_2","first-page":"601","article-title":"Effect of chemotherapy for the dysmyelopoietic syndrome","volume":"65","author":"Armitage JO","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb06081.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00172075"},{"key":"e_1_2_1_9_2","first-page":"164","article-title":"A phase II trial of oral 4\u2010demethoxydaunorubicin in patients with measurable advanced carcinoma of the breast","author":"Bastholt L.","year":"1985","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_10_2","volume-title":"Idarubicin in advanced lymphomas. Symposium: Progress in anthracycline therapy","author":"Harper P.","year":"1985"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92676-X"},{"key":"e_1_2_1_12_2","first-page":"981","article-title":"Phase I clinical trial of 13\u2010cis\u2010retinoic acid in myelodysplastic syndromes","volume":"67","author":"Gold EJ","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_13_2","article-title":"A randomised trial of retinoic acid and cytosine arabinoside in the treatment of myelodysplastic syndrome (MDS)","author":"Clark RE","year":"1985","journal-title":"British Society for Haematology"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1987.tb00770.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1987.tb00770.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:34:57Z","timestamp":1711632897000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1987.tb00770.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["10.1111\/j.1600-0609.1987.tb00770.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1987.tb00770.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}